SLATE-001 is under clinical development by Gritstone Bio and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase II drugs for Pancreatic Ductal Adenocarcinoma ...

Tom Hounsell, who had stepped up as interim head coach after Robinson left, was offered the chance to stay on the staff but has decided to move on. Club legend John Brayford is staying as first team ...

Vaccine maker Gritstone bio Inc. has completed auctions that could lead to asset sales worth near $26 million, according to a notice dated Friday. Hercules Capital Inc. successfully bid the company’s ...

生物科技公司Gritstone bio, Inc.在最近的8-K文件中披露，该公司在2024年10月10日自愿申请第11章破产后，已拍卖其资产。 根据InvestingPro数据，该公司一直背负着巨额债务，债务权益比为4.62，Altman Z-Score为-9.84，表明严重的财务困境。从周一到周四进行的拍卖，导致 ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from Gritstone bio ( (GRTSQ)). Gritstone bio, Inc., a biotechnology company ...

It is developed based on Edge neoantigen platform, lipid nanoparticle (LNP) technology, and ZVex platform. It was also under development for colon cancer. Gritstone Bio (Gritstone) is a clinical-stage ...